Transdermal absorption enhancement of n-terminal tat-GFP fusion protein (TG) loaded in novel low-toxic elastic anionic niosomes

Journal of Pharmaceutical Sciences

Volumn 100, Issue 4, 2011, Pages 1525-1534

  Manosroi, Jiradej ^a   Lohcharoenkal, Warangkana ^a   Götz, Friedrich ^b   Werner, Rolf G ^c   Manosroi, Worapaka ^a   Manosroi, Aranya ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Cell culture; Cytotoxicity; Nanoparticles; Peptide; Protein delivery; Tat GFP; Transdermal

Indexed keywords

AMINO TERMINAL TAT FUSION GREEN FLUORESCENT PROTEIN; CHOLIC ACID; DEOXYCHOLATE SODIUM; HYBRID PROTEIN; NIOSOME; UNCLASSIFIED DRUG; ANION; GREEN FLUORESCENT PROTEIN; LIPOSOME; TRANSACTIVATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CELL METABOLISM; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; ELASTICITY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANIMAL; CELL LINE; CHEMISTRY; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; SKIN; SKIN ABSORPTION; SPRAGUE DAWLEY RAT; TOXICITY;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANIONS; CELL LINE; ELASTICITY; GENE PRODUCTS, TAT; GREEN FLUORESCENT PROTEINS; HUMANS; LIPOSOMES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; SKIN; SKIN ABSORPTION;

EID: 79951871507     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22355     Document Type: Article

References (37)

1. Uchegbu IF, Vyas SP. 1998. Nonionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33-70.
2. Patil SD, Rhodes DG, Burgess DJ. 2004. Anionic liposomal delivery system for DNA transfection. AAPS J 6(4):29.
3. Mozafari MR, Reed CJ, Rostron C. 2007. Prospects of anionic nanolipoplexes in nanotherapy: Transmission electron microscopy and light scattering studies. Micron 38(8):787-795.
4. Cevc G. 1995. Chapter 9: Material transport across permeability barriers by means of lipid vesicles. In Handbook of physics of biological systems; Lipowsky R, Ed. Vol. I. Amsterdam, the Netherlands: Elsevier Science, pp 441-466.
5. Cevc G. 1996. Lipid suspensions on the skin. Permeation enhancement, vesicle penetration and transdermal drug delivery. Crit Rev Therap Drug Carrier Sys 13:257-388.
6. Gompper G, Kroll D. 1995. Driven transport of fluid vesicles through narrow pores. Phys Rev E 52:4198-4208.
7. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. 2000. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 65:403-418.
8. Manosroi A, Jantrawut P, Manosroi J. 2008. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 360:156-163.
9. Baker RC, Kramer RE. 1999. Cytotoxicity of short-chain alcohols. Annu Rev Pharmacol Toxicol 39:127-50.
10. Jain S, Sapre R, Tiwary AK, Jain NK. 2005. Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: Development, characterization, and performance evaluation. AAPS Pharm Sci Tech 6: Article 64. Accessed on: April 30, 2010.
11. Lee EH, Kim A, Oh YK, Kim CK. 2005. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26:205-210.
12. Hiruta Y, Hattori Y, Kawano K, Obata Y, Maitani Y. 2006. Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Control Release 113:146-154.
13. Honeywell-Nguyen PL, Bouwstra JA. 2005. Vesicles as a tool for transdermal and dermal delivery. Drug Discovery Today Technol 2:67-74.
14. Manosroi J, Lohcharoenkal W, Götz F, Werner RG, Manosroi A. 2010. Cellular uptake enhancement of GFP-Tat fusion protein loaded elastic nanovesicles. Submitted to BBA-General subjects.
15. Bradford MA. 1976. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
16. Kikuchi H, Suzuki N, Ebihara K, Morita H, Ishii Y, Kikuchi A, Sugaya S, Serikawa T, Tanaka K. 1999. Gene delivery using liposome technology. J Control Release 62:269-277.
17. Manosroi A. Khanarin P, Götz F, Werner RG, Manosroi A. 2010. Entrapment enhancement of peptide drugs in niosomes. Journal of Microencapsulation 27:272-280.
18. Cevc G, Blume G, Schätzlein A. 1997. Transfersomes-mediated transepidermal delivery improves the regio-specificity and biological activity of corticosteroids in vivo. J Control Release 45:211-226.
19. Jain P, Umamaheshwari RB, Jain NK. 2003. Transfersomes-a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Development and Industrial Pharmacy 29:1013-26.
20. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. 1990. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82:1107-1112.
21. Plessis J, Egbaria K, Weiner N. 1992. Influence of formulation factors on the deposition of liposomal components into the different strata of the skin. J Soc Cosmet Chem 43:93-100.
22. Verma DD, Fahr A. 2004. Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A. J Control Release 97:55-66.
23. Persson D, Thoré Per EG, Nordén B. 2001. Penetratin-induced aggregation and subsequent dissociation of negatively charged phospholipid vesicles. FEBS Lett 505:307-312.
24. Choi MJ, Maibach HI. 2005. Liposomes and Niosomes as Topical Drug Delivery Systems. Skin Pharmacol Physiol 18:209-219.
25. Manosroi A, Khositsuntiwong N, Götz F, Werner RG, Manosroi J. 2009. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles, Journal of Liposome Research 19:91-98.
26. Maghraby GMM, Williams AC, Barry BW. 2004. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm 276:143-161.
27. Lόpez-Pinto JM, González-Rodríguez ML. 2005. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm 298:1-12.
28. Brgles M, Jurašin D, Sikiríc MD, Frkanec R, Tornašić J. 2008. Entrapment of ovalbumin into liposomes-factors affecting entrapment efficiency, liposome size and zeta potential. J Liposome Res 18(3):235-248.
29. Ekwall B, Silano V, Paganuzzi-Stammati A, Zucco F. 1990. Short-term toxicity tests for nongenotoxic effects. Chapter 7: Toxicity tests with mammalian cell cultures. John Wiley & Sons Ltd., Hoboken, NJ, USA.
30. Gaginella TS, Haddad AC, Go VL, Phillips SF. 1977. Cytotoxicity of ricinoleic acid (castor oil) and other intestinal secretagogues on isolated intestinal epithelial cells. J Pharmacol Exp Ther 201(1):259-266.
31. Sakai M, Imai T, Ohtake H, Otagiri M. 1998. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers. J Pharm Pharmacol 50(10):1101-1108.
32. Mizoguchi H, Hara S. 1998. Permeability barrier of the yeast plasma membrane induced by ethanol. J Ferment Bioeng 85(1):25-29.
33. Heerklotz H. 2008. Interactions of surfactants with lipid membranes. Q Rev Biophys. 41:205-264.
34. Aizawa S, Cabanac M. 2000. Temperature gradient across the skin's layers has no influence on local skin vasomotor responses. J Therm Biol 25:313-316.
35. Danet AR, Préat V. 2003. Transdermal delivery of timolol by electroporation through human skin. J Control Release 88:253-262.
36. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J. 1994. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci 91:664-668.
37. Tseng Y, Liu J, Hong RL. 2002. Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and Tat: A kinetic and efficacy study. Mol Pharmacol 62:864-872.